Upstream single-use bioprocessing systems: Future market trends and growth assessment

BioProcess International

Volumn 10, Issue 2, 2012, Pages 12-19

  Rader, Ronald A ^a,b   Langer, Eric S ^c  

^a BioPlan Associates   (United States)

^b Biotechnology Information Institute   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIVE AGENT; MONOCLONAL ANTIBODY; PLASTIC; POLYMER; STAINLESS STEEL;

BIOPROCESS; BIOREACTOR; CELL CULTURE; CONTAINER; DRUG INDUSTRY; FOOD PACKAGING; GOOD MANUFACTURING PRACTICE; IMMUNOGENICITY; MIXER; NONHUMAN; POLYMERIZATION; PROCESS TECHNOLOGY; PROTEIN STRUCTURE; SCALE UP; SHORT SURVEY;

EID: 84857276310     PISSN: 15426319     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Short Survey

References (4)

1. Langer ES. Eighth Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production. BioPlan Associates, Inc.: Rockville, MD, April 2011.
2. Rader RA. BIOPHARMA: Biopharmaceutical Products in the US and European Markets, 10th edition. Online database at www.biopharma.com.
3. Stone TE. Managing E/L [Extractables/Leachables] in Single-Use Systems: Regulatory and Scientific Directions in Assessing Health Risks. Contract Pharma April 2011: 44-49.
4. Pollock C, et al. Pure Red Cell Aplasia Induced By Erythropoiesis- Stimulating Agents. Clin. J. Am. Soc. Nephrol. (3)1 2008: 193-199.